Clinical Trial Update: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing anidulafungin to caspofungin for deep tissue infections due to Candida was terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Fungemia

Drugs mentioned

• Cancidas (caspofungin)
• Eraxis (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis, Fungemia | Phase 3 | Status: TERMINATED | Results posted: 2013-08-01